Valid cardiac biochemical markers. Part II
This publication is a continuation of the review of cardiac biomarkers approved by the Food and Drug Administration (USA), including analysis of prospective research, clinical trials and meta-analyses. In the first part, along with data on general concepts, definitions and classification of biomarke...
Saved in:
| Main Authors: | N. G. Gumanova, M. V. Klimushina, N. L. Bogdanova, O. V. Stefanyuk, V. A. Metelskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2020-11-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2588 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valid cardiac biomarkers. Part I
by: V. A. Metelskaya, et al.
Published: (2020-09-01) -
Discussion of a new classification for coronary artery disease
by: A. S. Galyavich
Published: (2020-03-01) -
Calcification markers and long-term outcomes of coronary artery bypass grafting
by: E. M. Stakhneva, et al.
Published: (2021-09-01) -
Echocardiographic correlates of cardiac fibrosis in patients with myocardial infarction and preserved left ventricular ejection fraction
by: N. V. Fedorova, et al.
Published: (2019-06-01) -
Left Dominant Coronary Circulation is Associated with Poorer Left Ventricular Function but Not Long-Term Mortality After ST Elevation Myocardial Infarction
by: Yusuf Bozkurt Şahin, et al.
Published: (2025-07-01)